AU Patent

AU2012224649A1 — Pharmaceutical compositions comprising metformin and a DPP-4 inhibitor or SGLT-2 inhibitor

Assigned to Boehringer Ingelheim International GmbH · Expires 2013-08-08 · 13y expired

What this patent protects

Patent listed against Jardiance.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012224649A1
Jurisdiction
AU
Classification
—
Expires
2013-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.